Major beta blocker mortality trials in chronic heart failure: a critical review. Heart. 1999;82(suppl 4):IV14 IV22. Altered adrenergic receptor sensitivity due to polymorphic variation.

Lopez-Sendon J, Swedberg K, McMurray J et al. Expert consensus document on β-adrenergic receptor blockers. Eur. Heart. J. 25(15), 1341–1362 (2004). Brodde OE. β-1 and β-2 adrenoceptor ...

angiotensin receptor blockers, sacubitril/valsartan (Entresto, Novartis), continued beta-adrenergic blockade, aldosterone antagonists and HMG-CoA reductase inhibitors. Early antithrombotic ...

Mice exhibit a well-documented circadian rhythm and ECG parameters comparable to humans, so the researchers pharmacologically blocked the SNS using the β-adrenergic receptor blocker, propranolol in ...

Atenolol blocks beta-1 receptors, which are present on the heart. This medication is a beta-blocker, prescribed for high blood pressure and to prevent heart pain and recurrence of heart attacks.

In humans, the possibility of reducing heart rate to extend lifespan has been explored primarily in patients with serious illnesses. For instance, beta-adrenergic receptor blockers, which reduce ...

Metoprolol is a beta 1-selective (cardioselective) adrenergic receptor blocking agent ... By blocking catecholamine-induced increases in heart rate, in velocity and extent of myocardial ...

Timolol (as maleate) 0.25%, 0.5%; oph soln; contains benzalkonium chloride. Timolol maleate is a beta 1 and beta 2 (non-selective) adrenergic receptor blocking agent that does not have significant ...